Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank29
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-22.98M
Near historical average
Percentile
P29
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-23.25M
Historical baseline
PeriodValueYoY Change
TTM$-22.98M+55.6%
2024$-51.78M-32.9%
2023$-38.96M-35.2%
2022$-28.81M-19.4%
2021$-24.13M-57.8%
2020$-15.29M-7.8%
2019$-14.18M-6.4%
2018$-13.33M+2.0%
2017$-13.60M-43.9%
2016$-9.45M-